Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 80,576 | 138,177 | 143,366 | 68,789 | 74,450 |
| Marketable Securities | 87,188 | 50,625 | 50,341 | N/A | N/A |
| Receivables | 21,537 | 18,348 | 23,878 | 22,732 | 22,113 |
| Other current assets | 15,559 | 15,453 | 12,870 | 11,630 | 14,334 |
| TOTAL | $204,860 | $222,604 | $230,456 | $103,151 | $110,897 |
| Non-Current Assets | |||||
| PPE Net | 2,142 | 2,128 | 2,271 | 1,938 | 2,439 |
| Investments And Advances | 369 | 358 | 360 | 0 | 360 |
| Intangibles | 10,140 | 10,007 | 10,152 | 10,343 | 10,289 |
| Other Non-Current Assets | 2,788 | 2,980 | 3,253 | 4,016 | 0 |
| TOTAL | $15,439 | $15,473 | $16,036 | $16,297 | $13,088 |
| Total Assets | $220,300 | $238,078 | $246,492 | $119,448 | $123,985 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,561 | 18,921 | 13,299 | 15,537 | 15,121 |
| Other current liabilities | 3,255 | 3,491 | 4,445 | 6,571 | 7,432 |
| TOTAL | $21,997 | $22,645 | $17,977 | $22,336 | $22,808 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 75,376 | 73,438 | 71,277 | 75,119 | 75,717 |
| TOTAL | $75,376 | $73,438 | $71,395 | $75,119 | $75,862 |
| Total Liabilities | $97,373 | $96,082 | $89,372 | $97,455 | $98,669 |
| Shareholders' Equity | |||||
| Common Shares | 9,211 | 8,859 | 8,859 | 8,847 | 7,342 |
| Retained earnings | -450,850 | -404,061 | -387,663 | -431,894 | -367,877 |
| Other shareholders' equity | 2,229 | 2,281 | 2,360 | -10,725 | 2,475 |
| TOTAL | $122,926 | $141,995 | $157,120 | $21,993 | $25,316 |
| Total Liabilities And Equity | $220,300 | $238,078 | $246,492 | $119,448 | $123,985 |